Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends (Q34926483)

5 August 2017

title

Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

Mathias W Pletz

3

0 references

Tobias Welte

5

object named as

Tobias Welte

1 reference

5 August 2017

Felix C Ringshausen

1

1 reference

5 August 2017

Andrés de Roux

2

1 reference

5 August 2017

Nina Hämäläinen

4

1 reference

5 August 2017

Jessica Rademacher

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

e71109

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

copyright license

start time

1 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Bronchiectasis--diagnosis and treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Azithromycin for prevention of exacerbations of COPD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

British Thoracic Society guideline for non-CF bronchiectasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

The pathophysiology of bronchiectasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Aetiology in adult patients with bronchiectasis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Measuring diagnoses: ICD code accuracy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

New Zealand national incidence of bronchiectasis "too high" for a developed country.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Bronchiectasis: not an orphan disease in the East

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Bronchiectasis. Third report on a follow-up study of medical and surgical cases from childhood

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Bronchiectasis in Finland: trends in hospital treatment

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Factors associated with bronchiectasis in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Bronchiectasis: an orphan disease with a poorly-understood prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071109

Validation of ICD-9 diagnostic codes for bronchopulmonary dysplasia in Quebec's provincial health care databases.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731262

Azithromycin in bronchiectasis: when should it be used?

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23936489

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0071109

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference